Chronic May 2026

: This follows a similar slide by 2025 prospect Will Johnson , who fell to the 47th pick over fears that chronic injuries would shorten his professional career [24].

: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34]. Chronic

: Teams like the San Francisco 49ers are under increasing pressure to avoid these "painful draft memories" and find durable stars to replace an aging roster [29]. 2. FDA Draft Guidance: A New Era for Pain Management : This follows a similar slide by 2025

On the health front, the FDA recently released a landmark draft guidance titled [1, 9]. This document aims to break the cycle of opioid reliance by accelerating the development of safer alternatives. : Use heat/cold therapy and pacing to manage

: Use heat/cold therapy and pacing to manage daily activity [25, 36].

In late April 2026, the word "chronic" has dominated two very different headlines: the medical evaluations of top NFL prospects and a pivotal shift in how the FDA approaches long-term pain management. 1. The NFL Draft: The "Chronic" Red Dot